Accès ouvert
2026
article
OpenAlex
V. Venanzi, S. Ciofini, E. Antonioli, G. Buda et autres
Background. The CASSIOPEIA phase 3 study compared two groups of MM patients eligible for autologous transplantation (TE) by adding the monoclonal antibody daratumumab to standard induction therapy (VTD), consolidation and maintenance for 2 years compared to observation. The study demonstrated a deeper …
it
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Dina Zucchi, Yasmine Houbaida, Chiara Tani, M.L. Del Giudice et autres
Background: Monoclonal proteins of a heterogeneous type appear to occur more frequently in patients with various autoimmune disorders, including systemic lupus erythematosus (SLE), with respect to the general population. In general population, monoclonal gammopathy of undetermined significance (MGUS) prevalence is estimated to …
it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
G. Barilà, Anna Pascarella, Concetta Conticello, Roberto Mina et autres
According to 2021 ESMO guidelines, treatment of newly diagnosed (ND) transplant eligible (TE) Multiple Myeloma (MM) patients is settled by an induction phase followed by single or tandem autologous stem cell transplantation (ASCT) and Lenalidomide (Len) maintenance. Before the recent approval of …
it
(code pays fourni par la source)
2008
article
OpenAlex
Paul Ritvo, Ronald E. Myers, M.L. Del Giudice, Larry Pazsat et autres
Psychosocial constructs have been used to predict colorectal cancer screening and are frequently targeted as intermediate outcomes in behavioral intervention studies. Few studies have conducted analyses to adequately test construct validity. The psychometric analyses undertaken with U.S. populations of 16 theory-based, colorectal …
ca, gb, us
(code pays fourni par la source)